Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Inovio Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +2 vs. Q3 2025
- Shares held
- 33.0M
- +12.3M (+59.5%) vs. Q3 2025
- Total value
- $57.5M
- +$9.01M (+18.6%) vs. Q3 2025
- New holders
- 20
- 25 more added
- Sold out
- 18
- 22 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $36.1M |
| Q1 2026 | 99 | $54.6M |
| Q4 2025 | 101 | $57.5M |
| Q3 2025 | 99 | $48.4M |
| Q2 2025 | 103 | $20.7M |
| Q1 2025 | 108 | $22.2M |
| Q4 2024 | 105 | $24.4M |
| Q3 2024 | 98 | $49.5M |
| Q2 2024 | 96 | $65.1M |
| Q1 2024 | 89 | $56.4M |
| Q4 2023 | 116 | $25.7M |
| Q3 2023 | 127 | $21.6M |
| Q2 2023 | 135 | $32.1M |
| Q1 2023 | 177 | $99.8M |
| Q4 2022 | 186 | $198.5M |
| Q3 2022 | 183 | $200.0M |
| Q2 2022 | 185 | $196.2M |
| Q1 2022 | 201 | $330.4M |
| Q4 2021 | 209 | $428.9M |
| Q3 2021 | 213 | $554.9M |
| Q2 2021 | 211 | $683.1M |
| Q1 2021 | 219 | $693.7M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 9,846,664 | $17.1M | 0.00% | +9,845,363+756,753.5% | Added |
| GMT Capital Corp | 0 | $0 | 0.00% | −126,119−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −110,068−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −65,065−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −37,991−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −19,455−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −14,289−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −12,977−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,402−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,330−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,497−100.0% | Sold out |
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Crowley Wealth Management, Inc. | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Groupe la Francaise | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |